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1. Introduction 
The economic costs associated with illnesses like influenza and the common cold are in the 
order of billions of dollars, arising from medical treatment, lost income and decreased 
productivity of ill workers. Acute respiratory diseases can be more severe for the young, 
elderly or immuno-compromised, causing complications and death in many cases.  
Transmission of respiratory diseases, including of respiratory syncytial virus (RSV), can be 
via small droplets that are able to remain suspended in the air and subsequently be inhaled 
by a susceptible host (Centers for Disease Control, 2010). However, little information is 
available on the specifics of transmission via aerosol droplets. A greater understanding of 
the fate of viruses in droplets, and the effect of physical factors that govern aerosol spread, is 
needed to control the spread of viral infections. The research undertaken in this study 
addresses some questions surrounding aspects of virus transmission via the aerosol route, in 
order to contribute to a more comprehensive understanding of this issue. 
1.1 Transmission of viral infections 
Respiratory infections can be spread by direct contact with an infected person, or by indirect 
contact with an intermediate contaminated object (fomite) (Goldmann, 2000). However, the 
mode of transmission of which the least information is available, is airborne transmission. 
This occurs when droplets, also known as bioaerosols, evaporate and become droplet 
nuclei,which are small residue droplets with diameters of less than 5 µm, that can remain 
suspended in the air for long periods of time (Fiegel et al., 2006). Droplet nuclei are thus 
associated with long distance transmission. 
Virus survival and spatial distribution of droplets are dependent on a number of factors, 
including droplet size and atmospheric conditions. Our knowledge of the mechanisms by 
which viruses are released into the air by humans or animals is somewhat limited, as is the 
nature of the association between the virus and its carrier particles. Furthermore, 
understanding of the mechanisms responsible for transport and spread of the agents in 
common types of indoor environments such as residential apartments, buildings, hotels and 
hospitals is also very limited. 
While studies have been conducted to characterise the distribution of such virus-containing 
droplets, results have varied widely. Most of these studies have used models to simulate 
natural aerosolisation, and until recently, no studies had examined the natural cough 
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droplet distribution of infected human subjects. A greater understanding of the fate of 
viruses in droplets, and the effect of physical factors that govern aerosol spread, is needed to 
control the spread of viral infections.  
Respiratory syncytial virus (RSV) is a medically important virus, and is one of the two major 
causes of lower respiratory tract (LRT) infections in infants and young children. Recently, it 
has also been recognised as important pathogens in adults, although the symptoms are less 
distinct and often the viral cause is not initially correctly identified (Hall, 2001). 
Additionally, there are no effective means of controlling the spread of this virus.  
There are two subtypes of RSV, serotypes A and B (Liolios et al., 2001). RSV is responsible 
for approximately 90,000 hospitalisations and 4,500 deaths in children aged six months and 
younger of the same age group, each year in the US alone. Stockton and colleagues stated 
that although the incidence of RSV in infants is known and widely documented, its 
contribution to morbidity and mortality in adults is unknown, and possibly under-
diagnosed (Stockton et al., 1998).  
Of the recognised mechanisms by which respiratory viruses can spread, some consider 
bioaerosols to be the principal mode of transmission (Couch et al., 1986). Others believe that 
direct and indirect contact is more to blame for spread of the disease. This issue remains 
contentious, with support on both sides, and evidence varying widely. However, it is 
generally agreed by most experts that airborne transmission of viruses is an issue requiring 
further investigation. As methods for droplet measurement and virus detection continue to 
become more sophisticated, more data is becoming available. 
1.2 Bioaerosols 
Bioaerosols have been defined as a collection of aerosolised biological particles (Cox and 
Wathes, 1995), which can vary depending on source, dispersal mechanisms and 
environmental conditions (Pillai, 2002). Bioaerosols themselves can be pathogenic, or can act 
as a vehicle for the dissemination of pathogens (Pillai and Ricke, 2002), such as fungi, 
bacteria or viruses. It is thought that many infections, particularly respiratory infections, can 
be transmitted between persons via airborne droplets from an infected person to an 
uninfected person. These droplets, or infectious aerosols, contain pathogens, which upon 
contact or inhalation may cause disease in a susceptible person. Therefore, bioaerosols 
contribute substantially to the transmission of many infectious diseases. Researchers, 
however, are unable to reach a consensus as to the significance of the airborne route in the 
transmission of respiratory diseases, due to a shortage of evidence for either argument. This 
can be attributed to past inadequate technologies, which were unable to fully recognise all 
facets of bioaerosol distribution. However, even with the aid of the more sophisticated 
technology that has become available over the last couple of decades, agreement between 
experts has still not been attained. 
Infectious bioaerosols can be generated from a number of sources, including sewage treatment 
plants (Carducci et al., 1999), toilets (Barker and Jones, 2005), and infected people. In this 
study, we are only interested in the latter, as they are undeniably implicated in the spread of 
respiratory infections like RSV. Droplets evaporate very quickly once they are released (in the 
order of milliseconds), and their size decreases to approximately half the original size of the 
droplet (Nicas et al., 2005). Weber states that “there is no unique and generally agreed upon 
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classification of airborne droplets, for example, concerning the aerodynamic diameter which 
defines the cut-off size between droplet nuclei and large droplets” (Weber and Stilianakis, 
2008) (page 362). Droplet nuclei are generally considered to be smaller than 10 µm in 
aerodynamic diameter, although some studies cite 5 µm as the cut off. 
It has been shown that viruses are more effectively spread by aerosol than bacteria or fungi 
(Carducci et al., 1999). Barker and Jones (2005)reported that in a controlled study on aerosols 
generated from toilets, twice as many viruses survived as bacteria. Viral diseases thought to 
be transmitted by infectious aerosol range from relatively mild conditions such as the 
common cold to more severe diseases, including severe acute respiratory syndrome (SARS), 
smallpox and influenza (Tseng and Li, 2005, Wang et al., 2005).  
1.2.1 Bioaerosol production 
The emission of respiratory droplets by people can occur via breathing, talking, coughing or 
sneezing (Edwards et al., 2004). Droplets are created when currents of air pass over the 
mucous linings in the respiratory tract, creating disturbances in the surface of the mucous. 
This can lead to the creation of droplets which break away from the bulk of the liquid 
(Fiegel et al., 2006). The production of droplets and aerosols is a complex process in the 
body, with many factors influencing the properties of the resulting particles. 
Droplets expelled from the respiratory tract differ in size depending on the exact point of 
creation. This is due to the physiology of the respiratory tract: as the diameter of the 
respiratory tract varies, air pressure and speed change accordingly (Morawska, 2006). For 
example, the trachea has a larger diameter than bronchioles, so the air pressure and speed is 
lower, and the resulting droplets theoretically should be larger in size and fewer in number. 
Talking and breathing activities generally tend to create droplets which are larger and fewer 
in numbers. Droplets from these activities are typically created in the mouth. Activities such 
as coughing produce droplets which are much smaller, and in greater numbers, usually 
from the lower sections of the respiratory tract. Droplets produced from coughing and 
sneezing have been reported to range in size from 1 to 100 µm by one study (Kowalski and 
Bahnfleth, 1998) and from 1 to 20 µm by another study (Knight, 1973). Papineni and 
Rosenthal (1997) reported that the quantity of droplets produced was highest in coughing 
compared to other respiratory activities. 
The properties of mucous and respiratory fluids will most probably introduce a further 
influential element in the creation of the resulting droplets. Edwards (1991) noted that high 
surface tension of mucous, which is found in infected individuals, favours the formation of 
relatively larger droplets; similarly, lower viscosity favours the formation of smaller 
droplets (Burkdolder and Berg, 1974). Differing compositions of respiratory fluids will 
require varying flow velocities in the respiratory tract to produce droplets, due to changed 
adhesion forces of the respiratory fluids (Papineni and Rosenthal, 1997). In an infected 
individual, these fluids will usually be more viscous, and therefore it can be inferred that 
droplets produced by such an individual will be different from that of a healthy individual. 
Therefore, droplets will vary in size, in the number of droplets produced, according to the 
type of respiratory activity and the health status of the individual.  
The creation of the droplet does not only affect the droplet physically, in terms of its fate in 
the environment, but ultimately it dictates whether or not the droplet will contain an 
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infectious particle. In this regard, we must consider the general pathologies of respiratory 
infections. The precise location of the infection in the respiratory tract is certainly the most 
important factor here. Some viruses, for instance rhinoviruses and other viruses causing the 
common cold, preferentially localise infection in the upper respiratory tract. Other viruses 
favour the lower respiratory tract. Parainfluenza viruses and respiratory syncytial viruses 
both replicate in the nasopharyngeal epithelium, and after a few days spread to the lower 
respiratory tract (Hall, 2001).  
1.2.2 Bioaerosol transport 
An area of specific interest of the three stages of aerosol transmission is transport of 
droplets. Bioaerosol transport in the air has been widely documented in field or model 
studies. However, fewer studies have examined the aerial transport and fate of droplets 
emitted by humans during breathing, coughing, sneezing or talking (Nicas et al., 2005). 
Even fewer studies have examined the detection of respiratory viruses in infected 
individuals; before 2007 there were no known studies that had achieved this. 
Morawska (2006) stated that the most important factor affecting particle fate is particle size. 
Additionally, particle size has a significant effect on the biological properties of a droplet. 
The initial size and concentration of the droplets alters dramatically upon release into the 
atmosphere, mostly due to evaporation. Droplets of pure liquid evaporate completely; thus, 
the degree by which the droplet evaporates is largely dependent on the water content and 
composition of the droplet. Interestingly, a recent study found that the dynamic evaporation 
of respiratory aerosols was very similar in speed to pure water droplets of a similar size; 
however this study only investigated dynamic evaporation in the order of seconds, and the 
findings do not preclude further drying of droplets over minutes or hours (Morawska et al., 
2008). Furthermore, it investigated droplets expelled by healthy individuals. If during 
respiratory infection, droplets have a higher mucous content (and thus less water content), 
the particle size may not decrease in size upon release, compared to a droplet with less 
mucous content (and more water content).  
Once the droplets have been released into the air, they are subjected to a number of forces 
that determine their distance and time of travel; these include Brownian motion, gravity, 
electrical forces, thermal gradients, electromagnetic radiation, turbulent diffusion, inertial 
forces and relative humidity (Pillai and Ricke, 2002). Brownian motion, which refers to the 
collision of the droplets with other molecules in the air, increases with rising temperature 
and decreasing size; particles larger than 1 m are generally more affected by gravity than 
Brownian motion (Pillai and Ricke, 2002) and may settle rapidly out of the air (Papineni and 
Rosenthal, 1997, Foarde et al., 1999). Other factors affecting droplet fate are the size, shape 
and quantity of the droplets.  
Information regarding droplets expelled by healthy individuals is relatively abundant. It has 
been reported that the size of droplets released by humans can range from 0.5 µm to 200 µm 
(Erdal and Esmen, 1995). Morawska and colleagues (2008) identified three distinct modes of 
aerosols during common expiratory respiratory activities: breath mode aerosol with a count 
median diameter (CMD) of <1 µm; a vocal cord vibration aerosol with a CMD near 3 µm; 
and a saliva aerosol mode near 10 µm. The number and concentration of particles is highly 
variable from person to person. Edwards and colleagues (2004) studied the release of 
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droplets by 11 subjects and were able to separate them into two groups based on the 
number of particles they exhaled. Whilst ‘high-producers’ expelled an average of 500 
particles per litre per six hours, ‘low-producers’ expelled an average of less than 500 
particles per litre per six hours. However, it must be noted that the subjects in the preceding 
studies were healthy volunteers, and that the droplets produced from healthy individuals 
are likely to be dynamically distinct from the droplets produced by infected people.  
Information on droplets expelled by infected individuals is vital to the understanding of 
transmission of infection, however, this issue has not been appropriately pursued. 
Additionally, publications describing particle size are not always clear as to whether droplet 
measurements refer to the initial droplet size (size before evaporation) or the dry droplet 
size (after evaporation) (Morawska et al., 2009). This difference is important, as evaporation 
plays a very important part in droplet fate. It is imperative to know the final size and 
composition of the droplets in question, so that their fate can be accurately predicted. 
The majority of reports published on bioaerosol transport have agreed on the most 
influential factors that affect virus transport in the air. The most commonly investigated 
environmental condition that has been documented is relative humidity (RH). It has been 
reported that some respiratory illnesses are less frequent in high RH (Wang et al., 2005); 
however this is not the case for all viruses, as one study found that rhinoviruses had a 
higher recovery rate at high RH. Lipid-enveloped viruses tend to have a greater stability at 
lower RH, usually below 40 % (Benbough, 1971, Pillai and Ricke, 2002).  
A review by Fiegel and co-workers (2006) concluded that both inhaled and exhaled 
bioaerosols could act as vectors for deep-lung and environmental transport of airborne 
disease. They also concluded that it is likely that a small percentage of the population would 
be responsible for dissemination of the majority of exhaled bioaerosols.  
Tang and co-workers (2006) conducted a review into aerosol transmission of infectious 
diseases within healthcare premises. From the data they gathered, the authors found 
evidence that infectious organisms are able to be transmitted over both short and long 
distances, and that some organisms associated only with short-range transmission can also 
cause outbreaks over greater distances via transmission of evaporated droplets. This review 
concluded that personal protective equipment is needed to prevent person-to-person short-
range transmission of infectious diseases. 
1.2.3 Bioaerosol reception 
The reception of droplets and subsequent risk of infection relies on the deposition of 
droplets in the respiratory tract, which in turn depends on a number of factors. The size of 
the droplet will determine the depth to which the droplet is able to penetrate the airways. A 
study conducted by Hatch (1961) found that the retention of particles in the respiratory tract 
is close to 100 % for particles with a diameter of about 5m; retention drops to about 20 % for 
particles of about 0.25 -0.5 m and then increases again to reach 60 % for sub-microscopic 
particles (smaller than 0.1 m). The majority of droplets that are 20 µm in diameter deposit 
in the nasal passages, with a small fraction depositing in the pharynx and larger bronchi 
(Knight, 1980). Foarde (1999) stated that nearly all 2 µm particles are deposited in the 
respiratory tract, whilst Daigle and colleagues (2003) found that deposition of particles 
increased as their size decreased.  
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The smaller the particles, the more likely they are to impact on the lower respiratory tract. 
Proctor (1966) stated that although few deposition studies have been conducted, it is likely 
that particles smaller than 5 m will penetrate to the lower respiratory tract. It has been 
reported that the main mechanism for deposition of particles with a diameter less than 
0.5 m is diffusion (Daigle et al., 2003), which can occur in the alveoli of the lungs (Wilson et 
al., 2002). Diffusion by smaller particles is more harmful because they can diffuse rapidly 
through the alveolar membrane into the blood (Hogan et al., 2005).  
Hinds (1982) described the fate of aerosol particles deposited in the respiratory tract as 
follows: the upper respiratory tract has a mucous lining that is propelled, along with the 
deposited particles, up toward the pharynx and swallowed; whereas the lower respiratory 
tract, including the alveolar regions, has no mucous lining, and clearance of particles is 
much slower and less efficient (Hinds, 1982). 
Once a bioaerosol has deposited in the respiratory tract, whether or not a disease state will 
eventuate is determined by the following: whether or not the virus in question is still intact 
and able to infect a cell; the location of deposition in the respiratory tract, and whether or 
not the virus can bind to the cells; and the immunological status of the individual. 
The spread of particles, and in particular bioaerosols, in indoor environments is a complex 
process, involving many factors. To understand more comprehensively the potential spread 
of disease in these situations, a more thorough understanding is required of both virus 
persistence in droplets and the physical factors which significantly affect it. 
1.3 Methods to study bioaerosol transport 
Bacteriophages have played a key role in various types of research. A particularly important 
application of bacteriophages is their use as models or surrogates. In these systems, they are 
used in place of other viruses to give an indication of how the virus in question may respond 
to particular conditions. Bacteriophages are viruses that infect bacteria, and are thus are not 
harmful to humans. This use of bacteriophage is important because they do not pose serious 
health risks and are relatively easy to propagate in the laboratory; therefore there are reduced 
risks and costs associated with the experiments. They are also readily available and have 
relatively simple detection assays (Van Cuyk et al., 2004). Many bacteriophages exist, and are 
classified based on their morphology. Like other viruses, the genome can consist of either 
single- or double-stranded DNA or single- or double-stranded RNA (Nelson, 2004). 
Surrogate bacteriophages are selected based on a simple set of general criteria. In an aerosol 
study, it is important to choose a bacteriophage that has similar aerosol characteristics to the 
specific viruses (in terms of aerodynamics and survival). MS2 is a commonly used 
bacteriophage in surrogate studies, including some studies investigating virus transmission 
in the air. Foarde and co-workers (1999) chose to use MS2 as a surrogate for various viruses 
including influenza, as it had similar shape and aerosol characteristics as human viruses, 
despite the fact that it is slightly smaller and non-enveloped. In another study, MS2 was 
used along with another E. coli phage, T3, to determine the best method for studying 
airborne viruses (Hogan et al., 2005). It was chosen as a surrogate as it had suitable size and 
shape, similar to that of commonly tested airborne viruses. Barker and Jones (2005) used 
MS2 to examine aerosol contamination caused by toilets. Furthermore, it has been used to 
compare the efficiencies of common air samplers (Tseng and Li, 2005). 
www.intechopen.com
 
Detection of Bacteriophage in Droplets 129 
An increasing number of studies have investigated the detection and/or survival of viruses 
in droplets; however extensive study of the persistence of respiratory viruses in aerosols has 
not been undertaken, nor has it been performed on the MS2 which is often used as a 
surrogate. Of particular interest is the quantification of virus survival when limiting factors 
are applied. As so few studies have been conducted regarding the actual aerosol 
characteristics of MS2 or common respiratory viruses, it is logical to begin with simulated 
studies so that they can provide a basis of comparison and assist in our knowledge and 
application of these methods to studies involving infected individuals. Moreover, it is 
important to simulate these studies as closely as possible to real-life so that fewer external 
factors need to be taken into account.  
1.4 Studies of aerosolised virus 
From previous simulated droplet experiments, it is known that virus survival and spatial 
distribution of droplets are dependent on a number of governing factors including 
aerodynamic droplet size and atmospheric conditions. Extensive studies examining the 
effect of temperature and relative humidity have also been conducted. Given that these 
factors have been described in the literature quite satisfactorily, they were not examined in 
this study. Instead, other limiting physical factors were investigated. 
Prior to 1995, virtually all studies that examined viral transport in aerosols used culture 
methods, by employing a suitable host cell layer to examine for infected regions or plaques. 
The number of plaques was taken to indicate the number of intact virus particles, hence the 
unit of PFU (plaque-forming-units) per unit volume was used. PFU has traditionally been 
used for such studies. However, it is now thought that only a fraction of viruses present 
may be capable of forming a plaque in a host layer after the aerosolisation process, due to 
physical damage to the virion, and thus the traditional methods very probably 
underestimate the actual number of infectious viruses remaining in the aerosols.  
In addition, there is no accurate information available as to how many intact virus particles are 
required for the infection of a host cell. Instinctively, the answer would be that just one virus 
particle per host cell was required, but this has not yet been proven conclusively. The general 
lack of research in this area can be attributed to a lack of suitable virus detection methods. 
The rapid development of PCR techniques has allowed more suitable application of this 
technique to the problem of detecting viruses in aerosols over the past decade. The shift 
towards the molecular detection method polymerase chain reaction, or PCR, in recent 
aerosol research, has presented a timely opportunity to design a method which allows 
collection, detection, and quantification of viruses in an air sample. This has allowed us to 
detect not only the “culturable” or intact virions in the aerosols, but all intact virus RNA. In 
developing such a method, it was important to note the likelihood of low viral 
concentrations in respiratory aerosols. 
2. Study of MS2 bacteriophage and respiratory viruses in aerosols 
The objective of our research was to develop a PCR assay to detect viruses in aerosols, and 
to characterise the fate of bacteriophage MS2 in aerosols produced from four different 
aerosol types, whilst varying physical factors. 
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2.1 Development of PCR assays to study viruses in aerosols 
Respiratory viruses can be spread by infectious aerosols, generated from infected persons. 
However, detection of viruses in aerosols is not sensitive enough to confirm the 
characteristics of virus aerosols. The aim of this study was to develop assays for respiratory 
syncytial virus (RSV) and MS2 bacteriophage, which are sufficiently sensitive to be used in 
aerosol studies. To achieve this, a two-step, nested real-time PCR assay was developed. 
Outer primer pairs were designed to nest each existing real-time PCR assay. The sensitivities 
of the nested real-time PCR assays were compared to those of existing real-time PCR assays. 
Both nested real-time PCR assays were applied in an aerosol study to compare their abilities 
to detect bacteriophage in air samples. Assays were also described for influenza A (H1N1 
and H3N3), influenza B, and parainfluenza virus 1, and are described in Perrott et. al (2009). 
2.1.1 Methods 
Primer sets for the nested real-time PCR assays were designed based on previously described 
TaqMan® assays for each virus (see table 1). Using Primer Express®, an outer primer pair was 
designed to nest each TaqMan® primer/probe set. The outer primer pairs were used in the 
first round of amplification, which included a reverse transcription step (RT-PCR), followed by 
a second round of amplification using the TaqMan® primers and probe. 
The first step of the assay was a conventional PCR and was performed using SuperScript™ III 
One-Step RT-PCR with Platinum® Taq DNA polymerase mastermix (Invitrogen, Vic., 
Australia). For the second step (TaqMan® assay), Universal mix (Applied Biosystems) was 
prepared by adding primers and probe to the reaction mix. The assays were performed on an 
Applied Biosystems ABI 7500 System, and results are reported in cycle threshold (Ct) values.  
 
Organism Reference 
Primer 
set 
Primer name Sequence (5’ -3’) 
Human 
Respiratory 
Syncytial 
Virus 
This study Outer 
RSV-F1 TATTTGCATCGCCTTACAGTC 
RSV-R1 CTAAGGCCAAAGCTTATACAG 
 
Inner 
RSVF AGTAGACCATGTGAATTCCCTGC 
RSVR 
GTCGATATCTTCATCACCATACTTT
TCTGTTA 
Probe RSV probe TCAATACCAGCTTATAGAAC 
MS2 
This study Outer 
MS2-F5O TGA ACA AGC AAC CGT TAC CCC 
MS2-R5O TAT CAG GCT CCT TAC AGG CAG C 
O’Connell 
et al., 2006
Inner 
MS2F5 GCT CTG AGA GCG GCT CTA TTG 
MS2R5 CGT TAT AGC GGA CCG CGT 
Probe MS2-5 probe CCGAGACCAATGTGCGCCGTG 
 
Table 1. All primers and probes used in this study are shown in this table. This includes the 
outer (or nesting) primer pairs as well as the existing TaqMan® primers and probes. 
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2.1.2 Results and discussion 
The real-time PCR assay for RSV detected the virus with a titre of 104 TCID50 at 25.64 Ct, 
with an endpoint of 10 TCID50, detected at 36.06 Ct (see figure 1). The nested real-time 
PCR assay detected the 104 TCID50 titre of virus at 15.97 Ct, nearly 10 cycles earlier than 
the real-time PCR assay. Moreover, the nested real-time PCR assay had an endpoint of 1 
TCID50, amplifying at 31.22 Ct. The PCR products had to be diluted 1:1000, due to an 
excess of product resulting from the first round PCR, which exhausted the reagents and 
prevented the reaction from proceeding after about 8 cycles. An excellent distribution for 
a 10-fold dilution series for this virus was displayed by this assay, with distribution 
intervals between 2.85 cycles and 4.98 cycles. The virus was detected at an average of 8.93 
cycles earlier by the nested real-time PCR assay than the real-time PCR assay, after the 
PCR products were diluted 1:1000. 
 
 
 
Fig. 1. RSV as detected by real-time PCR (left) and nested real-time PCR (right) 
 
Virus titre (TCID50) 105 104 103 102 10 1 0.1 
RSV 
Real-time 
 
25.64 
Ct 
28.92 
Ct 
32.63 
Ct 
36.06 
Ct 
ND ND 
Nested 
 
15.97 
Ct 
19.79 
Ct 
23.39 
Ct 
28.37 
Ct 
31.22 
Ct 
ND 
Virus titre (PFU)  10
4 103 102 10 1 0.1 
MS2 
Real-time 
 
23.11 
Ct 
26.33 
Ct 
30.63 
Ct 
33.50 
Ct 
ND ND 
Nested 
 
7.42 Ct 9.27 Ct 
12.39 
Ct 
16.02 
Ct 
19.18 
Ct 
19.31 
Ct 
Table 2. This table shows the results of the real-time and nested real-time PCR assays for 
detection of RSV and MS2 at several concentrations. The results displayed are cycle 
threshold values. 
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For MS2, the real-time PCR assay, as described by O’Connell et al (2006), had an endpoint of 
10 PFU, detected at 33.50 Ct. In contrast, the nested real-time PCR assay was able to detect 
as low as 0.1 PFU at 19.31 cycles. Furthermore, the nested assay was also able to detect MS2 
at much earlier cycles in comparison with the non-nested assay. Whilst the highest dilution 
(104 PFU) was detected by the real-time PCR assay at 23.11 Ct, it was detected by the nested 
real-time PCR assay at 7.42 Cts. The nested real-time PCR assay for MS2 improved the 
detection of the virus dilutions by an average of 17.11 cycles in comparison to the real-time 
PCR assay. The distribution of the series, using the nested real-time PCR assay, was good 
and intervals were from 1.85 cycles to 3.63 cycles. 
Both the real-time PCR assay for MS2 and the nested real-time PCR assay for MS2 were used 
to detect MS2 bacteriophages from samples collected by gravitational settling, in order to 
determine which assay was more sensitive. Whilst the real-time PCR assay was only able to 
detect the virus from one air sample, the nested real-time PCR assay amplified MS2 from 14 
out of the 16 samples, as seen in figure 2. All amplified samples were detected from 8.65 to 
37.73 Cts.  
 
 
Fig. 2. The application of the real-time assay (left) and the nested real-time assay (right) to 
air samples 
Further to the development of the nested real-time PCR, it was necessary to develop a 
standard curve to quantify the collected viruses. It was decided that a synthetic RNA 
standard was the most appropriate option; this circumvented the problem of extraneous 
DNA and RNA in viral RNA extracted from the viruses, which can give a falsely 
increased amount of RNA. The synthetic RNA was constructed from DNA 
oligonucleotides and underwent several clean up steps to ensure the quality of the RNA 
was appropriate for PCR.  
Quantification of MS2 bacteriophage in aerosol samples using this method is described in 
the following section. 
2.2 Bacteriophage in aerosols 
The objective of this study was to apply the PCR method to detect the presence of the viral 
RNA in aerosols, and to compare its sensitivity and accuracy for estimation of viruses 
through detection of RNA, with that of the traditional plaque assay. 
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2.2.1 Methods 
A Perspex chamber of approximately 150 L was used for all air testing experiments. 
Aerosols were created and delivered into the chamber with the Collison six-jet nebuliser 
(BGI Inc, Waltham, US), operated at a flow rate of six litres per minute (L/min), the air flow 
required to produce aerosols with a size of around 2 µm. Aerosol collection was performed 
using a six stage Andersen impactor. A collection plate with an E. coli overlay was placed 
into each of the six stages and each experiment was performed in triplicate. Plaques were 
counted the following day, and the positive-hole correction method was applied. Average 
(mean) counts were then calculated for each experiment.  
We explored the following factors: concentration of virus in the nebulising suspension 
(105 to 103 PFU/mL); elapsed time between aerosolisation and sampling (0, 2, 5, 10 and 20 
minutes); and the type of droplets (‘wet droplets’ were delivered directly into the chamber 
from the Collison, and ‘dry droplets’ which were mixed with sterile air at about 12 L/min, 
in order to dry the droplets before they were delivered into the chamber). Aerosolisation 
was performed for 30 seconds for each experiment.  
Two types of nebulising suspension were used: traditionally-used phosphate buffered saline 
(PBS) and an artificial mucous (0.4 %), as described by King et. al (1985). Theoretically, the 
artificial mucous simulates an infected persons respiratory secretions more accurately than a 
water-like, non-viscous fluid. Thus, four droplet types were tested. 
2.2.2 Results and discussion 
2.2.2.1 Effect of droplet type 
The UV-APS showed that the majority of droplets produced by the six-jet Collison 
nebuliser, when operating at six L/min, ranged in aerodynamic diameter from less than 
0.523µm to 2.1 µm. The four types of droplets created by the Collison (wet and dry droplets 
from the artificial mucous suspension and the PBS suspension) differed slightly in size (see 
table 3). The droplets with the largest diameter were the wet droplets generated from PBS, 
with a mode of 0.980 µm. In comparison, the mode of the dry droplets from the same 
suspension was 0.965 µm. The artificial mucous droplets were smaller again: wet droplets 
from this suspension had a mode 0.910 µm; dry droplets had a mean diameter of 0.835 µm. 
 
Sample Median 
(µm) 
Aerodynamic 
mean (µm) 
Geometric 
mean (µm) 
Mode 
(µm) 
Concentration of 
droplets/cm3 
PBS wet 1.100 1.226 1.166 0.980 15,000 
PBS dry 1.023 1.087 1.057 0.965 2303 
AM wet 0.915 0.976 0.935 0.910 1842 
AM dry 0.850 0.884 0.860 0.835 412 
Table 3. Size distributions and droplet concentration of the four types of droplets used in 
this study, as measured using the UV-APS  
The number of droplets was considerably different. There was a much higher concentration of 
droplets created from the PBS suspension, especially when wet droplets were aerosolised from 
the PBS suspension. A concentration of 15,000 droplets per cm3 was measured using the UV-
APS, whereas when wet droplets were aerosolised from the artificial mucous suspension, a 
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concentration of only 1842 droplets per cm3 was recorded. When dry droplets were aerosolised 
from the PBS suspension, the average number of droplets per cm3 was 2303; from the artificial 
mucous suspension, an average of 412 droplets per cm3 was recorded. 
2.2.2.2 Effect of elapsed time on MS2 as detected by the plaque assay and the PCR assay 
When MS2 was aerosolised in PBS wet droplets, the recovery rates of MS2 RNA copies were 
higher than those of the infectious particles. When wet droplets were collected immediately 
after aerosolisation (elapsed time = 0 minutes), 0.171 % of the infectious viruses were 
recovered from the original challenge by the plaque assay. However, the nested real-time 
PCR assay detected 1.03 % of the RNA copies, an average of 1,324,558 (± 780,684) RNA 
copies, from the original challenge. After a time elapse of two minutes, infectious MS2 levels 
as detected by the plaque assay, dropped to 0.001 %. However, the recovery rate of RNA 
copies dropped to only 0.42 % when detected by the nested real-time PCR assay, with an 
average of 547,496 (± 381,113) RNA copies detected. After five minutes elapsed time, the 
plaque assay showed that levels of infectious viruses dropped to 0.004 %, and then to 
0.0002 % after 10 minutes elapsed between aerosolisation and collection. No infectious 
viruses were detected at the 20 minutes elapsed time point. The nested real-time PCR assay, 
on the other hand, detected 636,653 (± 274,203) RNA copies after five minutes elapsed, 
equating to 0.49 % of the original challenge. The virus level then decreased to 0.28 % at ten 
minutes with 365,052 (± 174,191) RNA copies detected; and at the last time point of 20 
minutes elapsed time, the virus recovery rate rose slightly with 267,856 (± 490,294) RNA 
copies detected (0.38 %). 
When MS2 was aerosolised from artificial mucous droplets, the nested real-time PCR assay 
was able to detect more relative RNA copies than infectious particles when collected after 20 
minutes elapsed time. Using the plaque assay, 3.474 % of the infectious particles generated 
from the artificial mucous suspension were recovered initially (data not shown here, see 
Section 5.3.1); this dropped to zero viruses detected at the 20 minutes time point. However, 
the nested real-time PCR assay detected 1.70 % of the original RNA copies immediately after 
release, which then dropped to 0.84 % after a 20 minute elapse time. 
When aerosolised in PBS dry droplets, the recovery, rate as measured by RNA copies, was 
comparable to the MS2 infectivity recovery rates. Upon immediate collection, 0.087% of the 
original challenge remained infectious; whilst 0.04% of the RNA copies were recovered from 
the original challenge, with 48,010 (± 6,859) RNA copies detected by the nested real-time 
PCR assay. The level of infectious viruses then dropped after a two minutes elapse to 
0.037%; meanwhile, an average of 9,677 (± 4437) RNA copies were detected, this indicated a 
recovery rate of 0.017% of the RNA copies from the original challenge. Infectivity remained 
at a similar level after five minutes elapsed: 0.032% of infectious MS2 was recovered as 
opposed to 0.007% of the RNA copies, which equated to an average of 9,643 (± 7,281) RNA 
copies. After ten minutes elapsed however, the level of infectious viruses dropped to 
0.001%. The nested real-time PCR assay showed that the rate remained at 0.006% of the 
original RNA copies. Finally, after 20 minutes elapsed, 0.011% of the original viruses 
remained infectious, whilst the rate of recovery of the RNA copies was 0.004%, with 
4,567 (± 1,751) RNA copies detected. 
When aerosolised in artificial mucous dry droplets, only 0.0003 % of the RNA copies were 
detected by the PCR. This is probably due to an experimental error. After a 20 minute 
elapsed time, 0.012 % of the RNA copies were recovered. This is in comparison to the plaque 
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assay which measured a relative recovery rate of 1.688 % infectious particles upon 
immediate collection. No infectious MS2 was detected after 20 minutes had elapsed. 
 
 
Fig. 3. The relative recovery of MS2 from the four different droplet types. Recoveries have 
been normalised to an initial challenge of 105 PFU, collected after different elapsed times of 
zero minutes, two minutes, five minutes and ten minutes 
 
 
Fig. 4. Recovery of MS2 RNA copies from droplets generated from a PBS nebulising 
suspension and collected after varying elapsed times, detected by the nested real-time PCR 
assay 
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Fig. 5. Recovery of MS2 RNA copies from droplets generated from an artificial mucous 
suspension after varying elapsed times, as detected by the nested real-time PCR assay 
A possible explanation for the almost immediate decay in MS2 infectivity, when held in the 
artificial mucous suspension, is that the suspension actually had a degrading effect on virus 
infectivity over time, as observed in an experiment examining this at different temperatures 
and times. It showed that when MS2 was held on ice, the numbers of infective MS2 
dramatically decreased: after 20 minutes, 58.58 % of the viruses were no longer able to form 
plaques, whereas when they were held in broth (used to propagate MS2 bacteriophage) and 
the PBS, the levels dropped by only 8.07 % and 23.08 % respectively. Given that the 
nebulising suspensions, within the Collison nebuliser, were kept on ice during the 
experiments and between replicates, this could certainly explain why the decay of MS2 
infectivity was so pronounced. 
Utrup and Frey found that 25 minutes following the initial aerosolisation, the levels of 
detectable MS2 had dropped by 28 % relative to the sample taken five minutes after 
aerosolisation (Utrup and Frey, 2004). This is a higher recovery than ours, however their 
methods and equipment differed, so realistically the results cannot be directly compared. 
2.2.2.3 Effect of virus concentration in the nebulising suspension 
For the PBS droplets, the results from the nested real-time PCR assay were similar to the 
plaque assay results, however, in all circumstances, the nested real-time PCR assay detected 
more viruses (relative to the original amount aerosolised) than the plaque assay (see figure 6 
and 7). From a challenge of 105 PFU (equivalent to 1.3 x 108 RNA copies), an average of 
1,324,558 (± 780,684) RNA copies were recovered (1.03 %) from wet droplets. A challenge of 
104 PFU (1.3 x 107 RNA copies) yielded an average recovery of 7013.23 (± 2685) copies, 
equating to 0.05 %; and an average of 518.13 (± 518.13) copies were recovered from the 
103 PFU (1.3 x 106 RNA copies) challenge (0.04 %). When dry droplets were aerosolised from 
the PBS suspension, the average recoveries, as measured by the nested real-time PCR assay, 
were also higher than the recoveries given by the plaque assay. An average of 
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48,010 (± 6,859) RNA copies was recovered from the 105 PFU challenge (0.037 %). Virus 
recovery increased slightly to 0.042 % when aerosolised from the 104 PFU challenge, with 
5408 (± 3193) RNA copies detected by the nested real-time PCR assay. No RNA was 
detected from the 103 PFU challenge. 
 
 
Fig. 6. Recovery of infectious MS2 from droplets generated from a PBS nebulising 
suspension of varying MS2 concentrations, as detected by the plaque assay 
 
 
Fig. 7. Recovery of MS2 RNA copies from aerosols generated from PBS nebulising 
suspensions of varying MS2 concentrations, as detected by the nested real-time PCR assay 
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Similar to the plaque assay results, no explainable trend was apparent when the nested real-
time PCR assay was used to detect MS2 in droplets from nebulising suspensions of varying 
concentrations (see figures 6-3 and 6-4). In the standard experiment for wet droplets, an 
average of 219,496 (± 71,923) RNA copies, or 0.17 % of the viruses from the original challenge 
introduced into the chamber was detected. This recovery dropped to 0.012 % from a 
nebulising suspension of 104 PFU/mL, with 1546 (± 1053) RNA copies detected; the recovery 
level then increased to 0.060%, or 775 (± 204) RNA copies, from the suspension containing 
103 PFU/mL of MS2.  
When aerosolised in dry droplets, the average rate of recovery increased with decreasing 
virus concentration in the nebulising suspension. This is not to say that the total numbers of 
RNA copies increased; rather the amount recovered relative to what was introduced into the 
chamber. The standard experiment yielded very low results (most likely as a result of 
experimental error) with a recovery rate of 0.0003 %, equivalent to 368 (± 306) RNA copies. 
The proportion of viruses recovered from the original suspensions of 104 PFU/mL increased 
to 0.068 % with the detection of 8765 (± 3118) RNA copies; this rate increased again for 
viruses aerosolised from the suspension of 103 PFU/mL, with 1222 (± 631) RNA copies 
detected, a relative recovery of 0.095 %. For the 105 PFU/mL challenge, more infectious MS2 
was recovered than RNA copies in the dry droplets (in relative terms of recovery). However, 
for the challenges with lower PFU, relatively more RNA copies were recovered from the 
original challenge than infectious MS2. 
 
 
 
 
 
 
Fig. 8. Recovery of infectious MS2 from aerosols generated from artificial mucous nebulising 
suspensions of varying virus concentration, as detected by the plaque assay 
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Fig. 9. Recovery of MS2 RNA copies from droplets generated from an artificial mucous 
suspension of varying MS2 concentration, as detected by the nested real-time PCR assay 
3. Conclusions 
We characterised four different droplet types and found that each droplet type had a 
significantly different effect on the persistence of viruses in the droplets. Most importantly, 
we demonstrated that the artificial mucous had a protective effect on virus infectivity, under 
certain conditions. We also showed that MS2 could be recovered from PBS droplets, with 
relative recovery rates of up to 0.17 % as detected by the plaque assay, and up to 1.03 % as 
detected by the nested real-time PCR assay. When aerosolised from artificial mucous 
droplets, MS2 was recovered with relative recovery rates of up to 3.474 % as detected by the 
plaque assay, and up to 1.110 % as detected by the PCR assay. 
We showed that when held in a PBS nebulising suspension, infectious MS2 bacteriophage 
could be detected by the plaque assay up to ten minutes following aerosolisation in wet 
droplets, and up to, and possibly beyond, 20 minutes after aerosolisation in dry droplets. 
When MS2 was aerosolised from the artificial mucus suspension, it was not detected in the air 
by the plaque assay at ten minutes or 20 minutes following aerosolisation (from wet or dry 
droplets). However, we believe this is due to the result of a combination of effects including: 
the decay over time of MS2 virus infectivity when held in artificial mucous suspension on ice; 
the damage inflicted by impaction onto the agar; and the reduced viral load in the droplets. 
When the concentration of MS2 was varied in the PBS nebulising suspension, the lower limit 
of detection of infectious viruses, using the plaque assay, was 104 PFU/mL for both wet and 
dry droplets. When the concentration was varied in the artificial mucus suspension, the 
plaque assay detection limit was a nebulising suspension virus concentration of 104 
PFU/mL for the dry droplets and 103 PFU/mL for the wet droplets.  
The differences between the PBS nebulising suspension and the artificial mucous 
suspension were interesting: it was clear that the artificial mucous suspension had a 
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protective effect on the MS2 infectivity on immediate release. Based on the standard 
experiment, more than 20 times the amount of viruses remained infectious (intact) when 
aerosolised from the artificial mucous suspension in comparison to droplets produced 
from the PBS suspension. It may follow that the physical properties of human mucous 
will have a protective effect on the viruses. 
The nested real-time PCR assay generally favoured the detection of MS2 in droplets. 
However, considering that there are a lot more viral copies of RNA present in a given 
sample than viruses which can form a plaque (an estimated 1292 copies to one PFU), this is 
not surprising. It is of course very likely that we will find more RNA copies than infectious 
viruses in a sample. Overall, the nested real-time PCR assay results were fairly comparable 
to the plaque assay in terms of trends against the variables tested. 
4. Significance 
This study sought to address the issue of to what extent viruses could survive given 
optimal conditions. It did not take into account all of the numerous factors which might 
influence aerial transmission including, but not limited to: bioaerosol production (location 
of virus in the respiratory tract; production of suitable droplets which viruses can be 
carried within, etc); transport (environmental factors such as temperature, relative 
humidity, UV desiccation etc); and reception of aerosols (deposition of droplets, location 
of deposition, ability of viruses to bind to, infect and replicate in cells). In other words, 
aside from the factors we have investigated here, the virus needs to also overcome the 
aerosolisation process, the transport process, remain infectious and find a suitable host in 
which to initiate disease. 
In addition to contributing to knowledge in the field of respiratory virus transmission, this 
study has developed several methods for studying both bacteriophage and respiratory 
viruses in air samples. Methods developed include: sensitive, quantitative nested real-time 
PCR assays for RSV as well as MS2 bacteriophage; aerosol collection methods for collecting 
bacteriophage using host-overlay agar plates; and an aerosol collection method for 
pathogenic viruses, suitable for applying PCR analysis. 
Sensitive, quantitative, nested, real-time PCR assays were developed as part of this study, 
and successfully applied to aerosol studies using MS2 bacteriophage and influenza virus. 
The assays were used in combination with synthetic RNA controls for preparation of 
standard curves against which the unknown samples were quantified. The PCR method we 
have developed here is not a perfect solution to the problems encountered in detecting 
viruses in droplets; however it is a strong step in the right direction. As evidenced by the 
large error and standard deviation values, it is clear that there are still problems with 
accurately quantifying viruses in air samples. However, we have developed an assay which 
is very sensitive and can detect viruses in droplets where plaque assays cannot. The 
information in this study, as well as the method development, can be applied to the study of 
respiratory viruses in droplets. 
We examined small droplets with a range of diameters spanning 0.65 - 2.1 µm, which is 
consistent with the range of respiratory droplets as reported by several studies (Knight, 
1973, Erdal and Esmen, 1995, Kowalski and Bahnfleth, 1998, Morawska et al., 2008). It is the 
transmission and recovery of intact viruses within these droplets, which become droplet 
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nuclei, that pertains to the aerosol spread of respiratory viruses. We have shown that these 
droplets can potentially be vehicles of virus transmission, notwithstanding the other factors 
which affect airborne infection (as mentioned above). Furthermore, droplets that equilibrate 
to a size smaller in diameter than 0.65 µm were not considered here, as they were not within 
the size range of the Andersen sampler. This does not mean that the viruses are not intact, 
but that our limit of detection cannot provide for such a small particle.  
We have also conducted aerosol research with influenza virus, which provided surprisingly 
robust and stable results (data not shown), considering prior assumptions that it is a labile 
virus. The recovery of influenza was neither higher nor lower than that of the MS2 
bacteriophage, overall. Rather, it was much more consistent with respect to the levels of 
virus remaining in the droplets. Whether or not this is due to the nature of virus stability is a 
question that cannot be answered absolutely by this study. It is possible that the differences 
in the efficacies of the nested real-time PCR assays may have contributed to this finding. In 
any case, it is possible that this may be the case for similar studies with RSV. 
In future studies, the elapsed times could be extended to up to hours, to see how long the 
relative amounts of RNA copies remain stable, and to see at approximately what endpoint 
they can still be detected. Again, the comparable levels of viruses aerosolised in wet droplets 
were much higher than the corresponding experiments where dry droplets were 
aerosolised. 
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